Vaxess Technologies

Bronze Sponsor

Vaxess Technologies is transforming home delivery of next generation therapies and vaccines.

Vaxess's MIMIX platform combines a proprietary transdermal patch and applicator, capable of delivering a wide range of therapies and vaccines. Advanced biomaterials used for the dissolvable microarray tips enable the greatest levels of dose delivery control and can be modified to deliver different payloads. Additionally, Vaxess’s MIMIX patch does not require refrigeration, enabling delivery to low resource settings.

Vaxess has raised approximately $100 million in grant and venture capital funding from groups such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, BARDA, DARPA, NIH, NSF and the Gates Foundation. The company has also generated strong clinical and in vivo proof of concept in the MIMIX platform with a wide range of molecules. For more information, please visit the company website at www.vaxess.com or send additional inquiries to contact@vaxess.com.

website